BH4 domain of Bcl-2 as a novel target for cancer therapy

BH4 domain of Bcl-2 as a novel target for cancer therapy

Item
http://www.wikidata.org/entity/Q36940766
Discovery and development of natural product oridonin-inspired anticancer agentsBCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.2-aryl benzimidazole conjugate induced apoptosis in human breast cancer MCF-7 cells through caspase independent pathway.Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.Dying to protect: cell death and the control of T-cell homeostasis.Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum-Mitochondrial Interface.Decreased WWOX expression promotes angiogenesis in osteosarcoma.TAT‑fused IP3R‑derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release.Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax.Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members.
P2860

BH4 domain of Bcl-2 as a novel target for cancer therapy

Item
http://www.wikidata.org/entity/Q36940766
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
BH4 domain of Bcl-2 as a novel target for cancer therapy
@en
type
label
BH4 domain of Bcl-2 as a novel target for cancer therapy
@en
prefLabel
BH4 domain of Bcl-2 as a novel target for cancer therapy
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
BH4 domain of Bcl-2 as a novel target for cancer therapy
@en
P2093
P2860
P304
P31
P356
10.1016/J.DRUDIS.2015.11.008
P433
P478
P50
P577
P5875
P698
P932